Additional file 5 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Additional file 1: of Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii

Tianshui Niu (6431468)
Qixia Luo (401575)
Yaqing Li (108567)
Yanzi Zhou (1292469)
Wei Yu (43094)
Yonghong Xiao (248558)

March 2019

Table S1. Source distribution of 210 strains of CRAB-BSI. Table S2. Drug resistance of A. baumannii....

Pharmacological Study of Cefoxitin as an Alternative Antibiotic Therapy to Carbapenems in Treatment of Urinary Tract Infections Due to Extended-Spectrum--Lactamase-Producing Escherichia coli

October 2016

Cefoxitin could be an alternative to carbapenems in extended-spectrum-beta-lactamase-producing Esche...

Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study

Roelofsen, Eveline E.
Abdulla, Alan
Muller, Anouk E.
Endeman, Henrik
Gommers, Diederik
Dijkstra, Annemieke
Hunfeld, Nicole G. M.
de Winter, Brenda C. M.
Koch, Birgit C. P.

September 2022

Aims: To describe the pharmacokinetics (PK) of cefotaxime as pre-emptive treatment in critically ill...

Additional file 6 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 6: Figure S4. Probability of target attainment for different levels of renal functio...

Additional file 4 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 4: Figure S2. Visual predictive check obtained with the final model

Additional file 3 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 3: Figure S1. Model prediction versus observed cefoxitin concentrations

Additional file 1 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 1: Table S1. Characteristics and outcome of patients presenting with cefoxitin-susce...

Additional file 8 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 8: Table S4. Univariate factors associated with the acquisition of cefoxitin-resista...

Additional file 7 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 7: Table S3. Univariate factors associated with cefoxitin treatment failure

Additional file 1: of Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Romain Guilhaumou (6529418)
Sihem Benaboud (6529421)
Youssef Bennis (6529424)
Claire Dahyot-Fizelier (4722108)
Eric Dailly (669752)
Peggy Gandia (6529427)
Sylvain Goutelle (6529430)
Sandrine Lefeuvre (6529433)
Nicolas Mongardon (6529436)
Claire Roger (6184940)
Julien Scala-Bertola (6529439)
Florian Lemaitre (6529442)
Marc Garnier (4177243)

March 2019

GRADE Table - First area - PK variability provides the GRADE Table summarizing the methods and the r...

Additional file 1: of Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation

Cyril Touchard (5643656)
Alexandra Aubry (243572)
Philippine Eloy (2541145)
Nicolas Bréchot (268869)
Guillaume Lebreton (4868992)
Guillaume Franchineau (5643659)
Sebastien Besset (5643662)
Guillaume Hékimian (5643665)
Ania Nieszkowska (20672)
Pascal Leprince (3442388)
Charles-Edouard Luyt (5643668)
Alain Combes (38880)
Matthieu Schmidt (5643671)

August 2018

Table S1. List of the data included into the multivariable mixed models. Table S2. Infection sites, ...

Additional file 5: Figure S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Marc Garnier (4177243)
Sacha Rozencwajg (4177231)
Tài Pham (4126480)
Sophie Vimont (305139)
Clarisse Blayau (4177249)
Mehdi Hafiani (4177240)
Jean-Pierre Fulgencio (4177237)
Francis Bonnet (4177246)
Jean-Luc Mainardi (430448)
Guillaume Arlet (305142)
Muriel Fartoukh (55470)
Salah Gallah (4177234)
Christophe Quesnel (288319)

June 2017

Comparison of the antimicrobial therapy-related costs between the conventional strategy (left) and t...

Additional file 1: of Antimicrobial exposure and the risk of delirium in critically ill patients

Jessica Grahl (6081098)
Joanna Stollings (3843850)
Shayan Rakhit (6081101)
Anna Person (6081104)
Li Wang (15202)
Jennifer Thompson (87960)
Pratik Pandharipande (6081107)
E. Wesley Ely (512549)
Mayur Patel (6081110)

December 2018

Table S1. Antimicrobial agents used in the critically ill cohort (organized by major class and frequ...

Additional file 1: of Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials

Yannick Wirz (5636450)
Marc Meier (4775451)
Lila Bouadma (147823)
Charles Luyt (5636453)
Michel Wolff (147901)
Jean Chastre (5636456)
Florence Tubach (77841)
Stefan Schroeder (5512685)
Vandack Nobre (4175917)
Djillali Annane (3732)
Konrad Reinhart (51097)
Pierre Damas (20576)
Maarten Nijsten (3477845)
Arezoo Shajiei (5636459)
Dylan deLange (5636462)
Rodrigo Deliberato (5636465)
Carolina Oliveira (5636468)
Yahya Shehabi (51763)
Jos van Oers (5636471)
Albertus Beishuizen (70118)
Armand Girbes (5594855)
Evelien de Jong (5512688)
Beat Mueller (300968)
Philipp Schuetz (33688)

August 2018

Figure S1. Assessment of risk of bias in included trials. Figure S2. Forrest plot based on aggregate...

Additional file 2: of In silico trials using Monte Carlo simulation to evaluate ciprofloxacin and levofloxacin dosing in critically ill patients receiving prolonged intermittent renal replacement therapy

Susan Lewis (2625226)
Weerachai Chaijamorn (3450464)
Alexander Shaw (3427703)
Bruce Mueller (3450461)

September 2016

Probability of target attainment of fluoroquinolones in virtual patients with different PIRRT settin...

Additional file 1: of Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii

Tianshui Niu (6431468)
Qixia Luo (401575)
Yaqing Li (108567)
Yanzi Zhou (1292469)
Wei Yu (43094)
Yonghong Xiao (248558)

March 2019

Table S1. Source distribution of 210 strains of CRAB-BSI. Table S2. Drug resistance of A. baumannii....

Pharmacological Study of Cefoxitin as an Alternative Antibiotic Therapy to Carbapenems in Treatment of Urinary Tract Infections Due to Extended-Spectrum--Lactamase-Producing Escherichia coli

October 2016

Cefoxitin could be an alternative to carbapenems in extended-spectrum-beta-lactamase-producing Esche...

Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study

Roelofsen, Eveline E.
Abdulla, Alan
Muller, Anouk E.
Endeman, Henrik
Gommers, Diederik
Dijkstra, Annemieke
Hunfeld, Nicole G. M.
de Winter, Brenda C. M.
Koch, Birgit C. P.

September 2022

Aims: To describe the pharmacokinetics (PK) of cefotaxime as pre-emptive treatment in critically ill...

Additional file 6 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 6: Figure S4. Probability of target attainment for different levels of renal functio...

Additional file 4 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 4: Figure S2. Visual predictive check obtained with the final model

Additional file 3 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 3: Figure S1. Model prediction versus observed cefoxitin concentrations

Additional file 1 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 1: Table S1. Characteristics and outcome of patients presenting with cefoxitin-susce...

Additional file 8 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 8: Table S4. Univariate factors associated with the acquisition of cefoxitin-resista...

Additional file 7 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 7: Table S3. Univariate factors associated with cefoxitin treatment failure

Additional file 1: of Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Romain Guilhaumou (6529418)
Sihem Benaboud (6529421)
Youssef Bennis (6529424)
Claire Dahyot-Fizelier (4722108)
Eric Dailly (669752)
Peggy Gandia (6529427)
Sylvain Goutelle (6529430)
Sandrine Lefeuvre (6529433)
Nicolas Mongardon (6529436)
Claire Roger (6184940)
Julien Scala-Bertola (6529439)
Florian Lemaitre (6529442)
Marc Garnier (4177243)

March 2019

GRADE Table - First area - PK variability provides the GRADE Table summarizing the methods and the r...

Additional file 1: of Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation

Cyril Touchard (5643656)
Alexandra Aubry (243572)
Philippine Eloy (2541145)
Nicolas Bréchot (268869)
Guillaume Lebreton (4868992)
Guillaume Franchineau (5643659)
Sebastien Besset (5643662)
Guillaume Hékimian (5643665)
Ania Nieszkowska (20672)
Pascal Leprince (3442388)
Charles-Edouard Luyt (5643668)
Alain Combes (38880)
Matthieu Schmidt (5643671)

August 2018

Table S1. List of the data included into the multivariable mixed models. Table S2. Infection sites, ...

Additional file 5: Figure S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Marc Garnier (4177243)
Sacha Rozencwajg (4177231)
Tài Pham (4126480)
Sophie Vimont (305139)
Clarisse Blayau (4177249)
Mehdi Hafiani (4177240)
Jean-Pierre Fulgencio (4177237)
Francis Bonnet (4177246)
Jean-Luc Mainardi (430448)
Guillaume Arlet (305142)
Muriel Fartoukh (55470)
Salah Gallah (4177234)
Christophe Quesnel (288319)

June 2017

Comparison of the antimicrobial therapy-related costs between the conventional strategy (left) and t...

Additional file 1: of Antimicrobial exposure and the risk of delirium in critically ill patients

Jessica Grahl (6081098)
Joanna Stollings (3843850)
Shayan Rakhit (6081101)
Anna Person (6081104)
Li Wang (15202)
Jennifer Thompson (87960)
Pratik Pandharipande (6081107)
E. Wesley Ely (512549)
Mayur Patel (6081110)

December 2018

Table S1. Antimicrobial agents used in the critically ill cohort (organized by major class and frequ...

Additional file 1: of Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials

Yannick Wirz (5636450)
Marc Meier (4775451)
Lila Bouadma (147823)
Charles Luyt (5636453)
Michel Wolff (147901)
Jean Chastre (5636456)
Florence Tubach (77841)
Stefan Schroeder (5512685)
Vandack Nobre (4175917)
Djillali Annane (3732)
Konrad Reinhart (51097)
Pierre Damas (20576)
Maarten Nijsten (3477845)
Arezoo Shajiei (5636459)
Dylan deLange (5636462)
Rodrigo Deliberato (5636465)
Carolina Oliveira (5636468)
Yahya Shehabi (51763)
Jos van Oers (5636471)
Albertus Beishuizen (70118)
Armand Girbes (5594855)
Evelien de Jong (5512688)
Beat Mueller (300968)
Philipp Schuetz (33688)

August 2018

Figure S1. Assessment of risk of bias in included trials. Figure S2. Forrest plot based on aggregate...

Additional file 2: of In silico trials using Monte Carlo simulation to evaluate ciprofloxacin and levofloxacin dosing in critically ill patients receiving prolonged intermittent renal replacement therapy

Susan Lewis (2625226)
Weerachai Chaijamorn (3450464)
Alexander Shaw (3427703)
Bruce Mueller (3450461)

September 2016

Probability of target attainment of fluoroquinolones in virtual patients with different PIRRT settin...

Additional file 1: of Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii

Tianshui Niu (6431468)
Qixia Luo (401575)
Yaqing Li (108567)
Yanzi Zhou (1292469)
Wei Yu (43094)
Yonghong Xiao (248558)

March 2019

Table S1. Source distribution of 210 strains of CRAB-BSI. Table S2. Drug resistance of A. baumannii....

Pharmacological Study of Cefoxitin as an Alternative Antibiotic Therapy to Carbapenems in Treatment of Urinary Tract Infections Due to Extended-Spectrum--Lactamase-Producing Escherichia coli

October 2016

Cefoxitin could be an alternative to carbapenems in extended-spectrum-beta-lactamase-producing Esche...

Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study

Roelofsen, Eveline E.
Abdulla, Alan
Muller, Anouk E.
Endeman, Henrik
Gommers, Diederik
Dijkstra, Annemieke
Hunfeld, Nicole G. M.
de Winter, Brenda C. M.
Koch, Birgit C. P.

September 2022

Aims: To describe the pharmacokinetics (PK) of cefotaxime as pre-emptive treatment in critically ill...

Additional file 5 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Abstract

Extracted data

Additional file 5 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Abstract

Extracted data

Related items

Related items